Structures published

Total: 9

4-[(E)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidinium picrate

C₁₂H₁₅F₂N₂O_,C₆H₂N₃O₇

Jasinski, Jerry P.Butcher, Ray J.Yathirajan, H. S.Mallesha, L.Mohana, K. N.

Acta Crystallographica Section E (2009) 65, 10 o2365-o2366

a=6.0926(4)Å b=13.5364(8)Å c=24.0417(14)Å

α=90.00° β=92.671(6)° γ=90.00°

Gabapentinium picrate

C₉H₁₈NO_2,C₆H₂N₃O₇

Li, Hongqi Yathirajan, H. S.Mallesha, L.Mohana, K. N.Narayana, B.

Acta Crystallographica Section E (2009) 65, 4 o783

a=11.576(2)Å b=7.7312(16)Å c=19.973(4)Å

α=90.00° β=91.425(2)° γ=90.00°

N-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfanyl}- 4-methoxyphenyl)-4-methylbenzenesulfonamide

C₂₂H₂₃BrN₄O₄S₂

Kant, Rajni Gupta, Vivek K.Kapoor, Kamini Kumar, Mohan Mallesha, L.Sridhar, M. A.

Acta Crystallographica Section E (2012) 68, 8 o2590-o2591

a=10.0321(3)Å b=17.4842(6)Å c=13.9095(4)Å

α=90.00° β=91.699(3)° γ=90.00°

N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)-2,4,6-trimethylbenzenesulfonamide

C₂₅H₂₉BrN₄O₃S₂

Kumar, Mohan Mallesha, L.Sridhar, M. A.Kapoor, Kamini Gupta, Vivek K.Kant, Rajni

Acta Crystallographica Section E (2012) 68, 9 o2767

a=9.3334(5)Å b=10.3635(4)Å c=27.8258(11)Å

α=90.00° β=92.924(4)° γ=90.00°

N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}- 4-methoxyphenyl)-4-methylbenzenesulfonamide

C₂₃H₂₅BrN₄O₃S₂

Kumar, Mohan Mallesha, L.Sridhar, M. A.Kapoor, Kamini Gupta, Vivek K.Kant, Rajni

Acta Crystallographica Section E (2012) 68, 10 o2831

a=9.8318(3)Å b=10.3822(3)Å c=13.4393(4)Å

α=96.654(3)° β=103.085(3)° γ=107.714(3)°

N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)benzenesulfonamide

C₂₂H₂₃BrN₄O₃S₂

Kumar, Mohan Mallesha, L.Sridhar, M. A.Kapoor, Kamini Gupta, Vivek K.Kant, Rajni

Acta Crystallographica Section E (2012) 68, 11 o3209-o3210

a=13.6081(6)Å b=14.5662(5)Å c=14.7502(7)Å

α=74.439(4)° β=69.077(4)° γ=62.581(4)°

N-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)-4-chlorobenzenesulfonamide

C₂₁H₂₀BrClN₄O₄S₂

Kumar, Mohan Mallesha, L.Sridhar, M. A.Kapoor, Kamini Gupta, Vivek K.Kant, Rajni

Acta Crystallographica Section E (2012) 68, 9 o2800

a=10.0311(3)Å b=17.3096(6)Å c=13.9223(4)Å

α=90.00° β=91.829(3)° γ=90.00°

N-[2-(5-Bromo-2-morpholin-4-ylpyrimidin-4-ylsulfanyl)-4-methoxyphenyl]- 2,4,6-trimethylbenzenesulfonamide

C₂₄H₂₇BrN₄O₄S₂

Kumar, Mohan Mallesha, L.Sridhar, M. A.Kapoor, Kamini Gupta, Vivek K.Kant, Rajni

Acta Crystallographica Section E (2012) 68, 11 o3061

a=10.2583(4)Å b=17.4727(6)Å c=14.4375(7)Å

α=90.00° β=97.199(4)° γ=90.00°

4-[(3-Chloro-2-methylphenyl)iminomethyl]phenol

C₁₄H₁₂ClNO

Manjunath, B. C.Abdoh, M. M. M Mallesha, L.Mohana, K. N.Lokanath, N. K.

Acta Crystallographica Section E (2012) 68, 11 o3191

a=7.5271(9)Å b=12.4095(15)Å c=12.5800(14)Å

α=90° β=90° γ=90°

Structures by: Mallesha L.

Total: 9

4-[(<i>E</i>)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidinium picrate

Gabapentinium picrate

<i>N</i>-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfanyl}- 4-methoxyphenyl)-4-methylbenzenesulfonamide

<i>N</i>-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)-2,4,6-trimethylbenzenesulfonamide

<i>N</i>-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}- 4-methoxyphenyl)-4-methylbenzenesulfonamide

<i>N</i>-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)benzenesulfonamide

<i>N</i>-(2-{[5-Bromo-2-(morpholin-4-yl)pyrimidin-4-yl]sulfanyl}-4- methoxyphenyl)-4-chlorobenzenesulfonamide

<i>N</i>-[2-(5-Bromo-2-morpholin-4-ylpyrimidin-4-ylsulfanyl)-4-methoxyphenyl]- 2,4,6-trimethylbenzenesulfonamide

4-[(3-Chloro-2-methylphenyl)iminomethyl]phenol